Yali Friedman
Yali Friedman, PhD is publisher of DrugPatentWatch.com.
Yali is also publisher of the Journal of Commercial Biotechnology and author of Building Biotechnology, which is used as a course text in dozens of biotechnology programs. He was also named one of the 100 most influential people in biotechnology by Scientific American.
Yali has strong exposure to leading issues in international biotechnology. He is editor of the Scientific American worldVIEW scorecard, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC, in Europe, and throughout Asia.
He can be reached at yali@DrugPatentWatch.com and on LinkedIn
Articles by Yali Friedman:
My Favourite Tipples from a business intelligence publisher
Wednesday, 7th June 2017
My Favourite Tipples are shared by Yali Friedman, publisher of DrugPatentWatch.com, a global intelligence database. He shares his favourite online tools for better international communication.
Vendor adoption of AI
Community session
23rd May 2024
AI prompting and AI-sourcing, US private companies, and Jinfo on YouTube
Blog posting
10th April 2024
April 2024 Update
YouTube video
10th April 2024
- AI prompting and AI-sourcing, US private companies, and Jinfo on YouTube
10th April 2024 - AI practical actions, prompting and outsourcing
6th March 2024 - GenAI and ESG wisdom of the Jinfo crowd
13th February 2024
- Jinfo Community session (TBC) (Community) 20th June 2024
- Vendor adoption of AI (Community) 23rd May 2024
- Offshore, outsource or AI-source? (Community) 16th April 2024